standard life and aviva clash over adviser charging.

.

on critical illness, 4.6 per cent of claims were declined due to the definition not being met and 2.3 per cent were due to misrepresentation..

.

.may 17, 2018.

.

yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital..

the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes...

guj - ???????

.

harvard medical school: "cgrp: a new era for migraine treatment."